Clinical Trials Directory

Trials / Completed

CompletedNCT03399149

Systematic Evaluation by an Intensivist of Hematological Malignancy Patients Presenting With Acute Respiratory or Hemodynamic Failure

Systematic Evaluation by an Intensivist of Hematological Malignancy Patients Presenting With Acute Respiratory or Hemodynamic Failure: Impact on Prognosis: A Monocentric Observational Before-after Study

Status
Completed
Phase
Study type
Observational
Enrollment
221 (actual)
Sponsor
University Hospital, Grenoble · Academic / Other
Sex
All
Age
18 Years
Healthy volunteers
Not accepted

Summary

Over the last two decades, the number of patients with hematological malignancies (HMs) admitted to the ICU increased and their mortality has dropped sharply. Patients with HMs increasingly require admission to the intensive care unit (ICU) for life-threatening events related to the malignancy and/or treatments, with immunosuppression being a major contributor. Whether the increase in ICU admissions is related to increased referrals by hematologists and/or to increased admissions by intensivists is unknown. The criteria used for ICU referral and admission decisions have not been extensively evaluated. Finally, the links between admission policies and treatment-limitation decisions are unclear, but ICUs with broad admission policies may change the treatment goals based on the response to several days of full-code management. The aim of this study is to evaluate the impact of a systematic evaluation by an intensivist of HMs patients presenting with acute respiratory and/or hemodynamic failure.

Conditions

Interventions

TypeNameDescription
OTHERSystematic evaluation by an intensivistimplementation of a standardized procedure for patient care in ICU

Timeline

Start date
2017-02-13
Primary completion
2018-11-01
Completion
2020-03-01
First posted
2018-01-16
Last updated
2022-11-07

Locations

2 sites across 1 country: France

Source: ClinicalTrials.gov record NCT03399149. Inclusion in this directory is not an endorsement.